Skip to main content

Table 3 Percentage of FN and FP rates according to value risk categories are reported

From: Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase

Risk Categories 11% 20% 30% 45% 50% 31%
% False negative (FN) 1% 3.5% 8.2% 18.4% 24.4% 8.9%
% False positive FP) 56.0% 45.6% 31.4% 15.6% 9.0% 30.1%